Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/08 → 4/1/10 |
A Phase 2, Open-label Trialto Evaluate the Effficacy and Safety of MGCD0103 Administered in Combiniation witgh Azacitidine(Vidaza) to Subjects with Relapsed or Refractory Hodgkins or non-Hodgkins Lymphoma and to Evaluate the Pharmacokinectics
- Hayslip, John (PI)